Knowledge-accelerated drug development

Kaydedildi:

Detaylı Bibliyografya
Yayımlandı:	Pharmaceutical Executive vol. 18, no. 4 (Apr 1998), p. 88-93
Yazar:	Mamelok, Richard D
Diğer Yazarlar:	Olson, Camilla
Baskı/Yayın Bilgisi:	MultiMedia Healthcare Inc.
Konular:	United States > US Clinical trials Decision making Methods Guidelines FDA approval Project management Pharmaceutical industry Compliance Computer based modeling Research & development > R&D Critical path Portfolio management Software Teams Planning Knowledge Cholesterol Design Drug dosages Designers Drug development
Online Erişim:	Citation/Abstract Full Text
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Diğer Bilgiler
Özet:	Knowledge-accelerated drug development is a step-by-step process that companies can adopt to take full advantage of state-of-the-art computer-assisted technology. At an operational level within projects, research teams can use knowledge-accelerated drug development to assess different trial designs by accounting for many more variables that affect outcome than traditional methods can accomplish. That allows the team to choose the best design. Moving from current clinical planning methodology to new technology that provides better assessments can occur in 4 sequential steps: 1. computer-based trials management, 2. computer-assisted trial design, 3. computer-assisted clinical program design, and 4. computer-assisted portfolio management.
ISSN:	0279-6570 2150-735X
Kaynak:	ABI/INFORM Global